Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/33667
Title: | Association of polymorphisms in NF kappa B1 promoter and NF kappa BIA gene with the development of antibodies against HHV-8 in HIV-infected individuals |
Authors: | GONCALES, Juliana Prado; SILVA JUNIOR, Jose Valter Joaquim; LOPES, Thaisa Regina Rocha; TOZETTO-MENDOZA, Tania Regina; GUIMARAES, Deborah de Farias; MORAIS, Viviane Martha Santos de; COELHO, Maria Rosangela Cunha Duarte |
Citation: | VIROLOGY, v.535, p.255-260, 2019 |
Abstract: | Human ganunaherpesvirus 8 (HHV-8) is the etiologic agent of Kaposi's sarcoma, multicentric Castleman's disease and primary effusion lymphoma. Like other herpesviruses, the HHV-8 may exhibit latent or lytic cycle, both regulated by viral and host factors. Regarding host factors, we analysed the association of polymorphisms in NE kappa B1 promoter (NE kappa B1-94 ins/del ATTG) and NF kappa BIA gene (NF kappa BIA 3'UTR A -> G) with the development of antibodies against latent or lytic antigens from HHV-8. The ins/del [OR 7.9 (95% CI 3.3-19.1), p < 0.001], AG [OR 12.3 (95% CI 4.3-34.9) p < 0.001], GG [OR 9.4 (95% CI 3.2-27.9), p < 0.001], ins/del + AG [OR 94.5 (95% CI 9.6-924.4), < 0.0001], ins/del + GG [OR 50.4 (95% CI 5.2-482.2, p < 0.0001] and G allele [OR 3.3 (95% CI 2.0-5.6), p < 0.001] were strongly related with the presence of antibodies to lytic antigens. This is the first association of polymorphisms in NF kappa B1 promoter and NF kappa BIA gene with the development of antibodies against HHV-8. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - IMT Artigos e Materiais de Revistas Científicas - LIM/52 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_GONCALES_Association_of_polymorphisms_in_NF_kappa_B1_promoter_2019.PDF Restricted Access | publishedVersion (English) | 517.12 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.